Note: Ingredients listed on restricted chemical lists
EC/CAS
215-540-4/1330-43-4
Name of the chemical
Disodium tetraborate
Concentration
5-<10%
General Information
Version
1,2
Revision date
2021-06-24
Product name
This MSDS covers the following products in all container sizes - REF 11161.xxxxx Natriumtetraborat / Borax-Lösung 5 % - REF 11396.xxxxx Natriumtetraborat / Borax-Lösung 0 25 % - REF 15680.xxxxx Methylenblau-Borax-Lösung 1 % wässrig
Product Synonyms
Sodium tetraborate / borax, aqueous solutions
supplier name
MORPHISTO GmbH
Manufacturer Name
MORPHISTO GmbH
Emergency telephone
Mainz, Germany, Tel +49(0)6131/19240
Icons in SDS
Company Information
company name
MORPHISTO GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
info@morphisto.de
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H319, H360FD
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
GB CLP Regulation
Hazard categories
Reproductive toxicity: Repr. 1B
Hazard statements
May damage fertility. May damage the unborn child. H319 Causes serious eye irritation. H360FD May damage fertility. May damage the unborn child.
2.2 Label elements
GB CLP Regulation
Hazardous Ingredients
disodium tetraborate, anhydrous; boric acid, disodium salt
Signal word
Danger
Precautionary statements
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P308+P313 IF exposed or concerned: Get medical advice/attention. P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P405 Store locked up.
Special rules for supplemental label elements for certain mixtures
Restricted to professional users.
2.3 Other hazards
The substances in the mixture do not meet the PBT/vPvB criteria according to REACH, annex XIII.